Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange Other stock markets 12:00:00 12/08/2026 pm IST			5-day change	1st Jan Change
2,214.00 ^JPY	+0.75%		+3.43%	-8.93%

01/07	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
22/06	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,43,826	3,43,217	4,15,318	3,83,847	4,59,384	3,85,471	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-16.09%	-	-
Enterprise Value (EV)	1,68,429	1,86,950	2,36,499	2,42,307	3,01,938	3,85,471	3,85,471	3,85,471
Change	-	11%	26.5%	2.46%	24.61%	27.67%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	16.8x	13.9x	14.6x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.77x	0.74x	0.74x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.7x	-3.11x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.12x	0.12x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.12x	0.12x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	7.8x	7.58x	7.34x
EV / EBIT	0x	0x	0x	0x	0x	11.2x	10.3x	10.1x
EV / FCF	0x	-0x	0x	-0x	0x	18.4x	23.6x	32.1x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.45%	4.24%	3.11%
Dividend per Share ²	54	57	70	63	68	71	79	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.23%	3.59%	3.87%
EPS ²	153.6	127.4	154.1	147.5	229.6	131.1	158	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	54.2%	50%	56.5%
Net sales ¹	25,85,643	26,96,069	28,58,500	29,61,051	31,04,064	31,88,539	32,79,596	33,40,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	49,400	50,836	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,453	37,402	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,486	27,351	26,886
Net Debt	-1,75,397	-1,56,267	-1,78,819	-1,41,540	-1,57,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,197.50	2,197.50	2,197.50
Nbr of stocks (in thousands)	2,02,370	2,02,369	1,86,870	1,81,789	1,81,719	1,75,413	-	-
Announcement Date	16/05/22	15/05/23	14/05/24	15/05/25	15/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ALFRESA HOLDINGS CORPORATION	16.76x	-	-	3.23%	242.03Cr
ABBOTT LABORATORIES	31.49x	4.25x	16.45x	2.34%	19TCr
MEDTRONIC PLC	20.55x	3.56x	12.51x	3.28%	12TCr
CENCORA, INC.	18.28x	0.21x	13.13x	0.72%	6.37TCr
HOYA CORPORATION	32.06x	8.01x	20.38x	1.24%	5.51TCr
BECTON, DICKINSON AND COMPANY	35.17x	3.38x	11.56x	2.16%	4.94TCr
DEXCOM, INC.	35.89x	6.31x	19.82x	-.--%	3.38TCr
MEDLINE INC.	44.07x	1.3x	11.84x	0.17%	3.07TCr
WEST PHARMACEUTICAL SERVICES, INC.	40.97x	7.18x	25.76x	0.26%	2.47TCr
TERUMO CORPORATION	20.49x	3.09x	11.59x	1.43%	2.39TCr
Average	29.57x	4.14x	15.89x	1.48%	5.9TCr
Weighted average by Cap.	29.07x	3.99x	15.42x	1.86%